Search results for "Adrenergic Uptake Inhibitors"

showing 10 items of 12 documents

Influence of St John's wort on catecholamine turnover and cardiovascular regulation in humans

2004

BACKGROUND: St John's wort (Hypericum perforatum) is a popular over-the-counter antidepressant. Its antidepressive effect has been attributed in part to inhibition of monoamine transporters and monoamine oxidase, on the basis of in vitro studies. METHODS: In a double-blind, randomized, placebo-controlled, crossover study, 16 healthy subjects (11 men and 5 women; mean age, 31 +/- 5 years) ingested either St John's wort (300 mg three times daily) or placebo for 7 days. Imipramine treatment (50 mg three times daily) in 7 subjects served as a positive control. After treatment, physiologic and biochemical tests included cardiovascular reflex testing, graded head-up tilt testing, and plasma catec…

AdultMaleNitroprussideImipraminemedicine.medical_specialtyPosturePharmacologyAutonomic Nervous SystemPlaceboMethoxyhydroxyphenylglycolNorepinephrine uptakeCardiovascular Physiological PhenomenaNorepinephrineCatecholaminesDouble-Blind MethodInternal medicineHeart rateSupine PositionmedicineHumansNitric Oxide DonorsPharmacology (medical)PeryleneAnthracenesPharmacologyCross-Over StudiesAdrenergic Uptake Inhibitorsbusiness.industryHemodynamicsHypericum perforatumEndocrinologyBlood pressureMonoamine neurotransmitterCatecholamine34-Dihydroxyphenylacetic AcidAntidepressantFemalebusinessHypericummedicine.drugClinical Pharmacology & Therapeutics
researchProduct

Enhancement of human cortico-motoneuronal excitability by the selective norepinephrine reuptake inhibitor reboxetine

2002

It has been proposed that norepinephrine plays a critical role in the modulation of cortical excitability, which in turn is thought to influence functional recovery from brain lesions. The purpose of the present experiments was to determine if it is possible to modulate cortical excitability with the selective norepinephrine reuptake inhibitor reboxetine in intact humans. Recruitment curve and intracortical facilitation, assessed by transcranial magnetic stimulation, were increased after oral intake of 8 and 4 mg reboxetine, in the absence of changes in motor threshold, intracortical inhibition, M-response, F-wave or H-reflex. These results demonstrate that reboxetine enhances cortical exci…

AdultMaleRecruitment NeurophysiologicalMorpholinesmedicine.medical_treatmentCentral nervous systemNorepinephrine (medication)MagneticsReboxetinemedicineHumansNeurorehabilitationAdrenergic Uptake InhibitorsElectromyographyGeneral NeuroscienceReboxetineMotor CortexNeural InhibitionEvoked Potentials MotorTranscranial magnetic stimulationmedicine.anatomical_structureCatecholamineReuptake inhibitorPsychologyNeuroscienceMotor cortexmedicine.drugNeuroscience Letters
researchProduct

Transdermal nortriptyline hydrocloride patch formulated within a chitosan matrix intended to be used for smoking cessation.

2010

The aim of this study was to prepare and characterize both physically and biopharmaceutically, a nortriptyline hydrochloride (NTP-HCl) patch formulated in chitosan.16 g of each chitosan patch formulation (I, II and III, see Table 1 ) was poured onto rectangular glass plates (64 cm²) at a height of 1 mm and dried for 24 h at room temperature. In order to characterize the chitosan patches, polarized microscopy, in vitro skin permeation studies by passive diffusion and iontophoresis and rheological and bioadhesion studies were performed.Polarized microscopy revealed the absence of aggregates and crystal forms of NTP-HCl in all transdermal patches after 30 days of storage. The rheological behav…

AdultMaterials scienceTransdermal patchPharmaceutical ScienceTransdermal PatchNortriptylinePharmacologyAntidepressive Agents TricyclicChitosanchemistry.chemical_compoundHumansTransdermalSkinPolarized light microscopyChitosanIontophoresisAdrenergic Uptake InhibitorsGeneral MedicineAdhesionPermeationIontophoresisMiddle AgedchemistryChemical engineeringNortriptyline HydrochlorideFemaleSmoking CessationPharmaceutical development and technology
researchProduct

Automated determination of reboxetine by high-performance liquid chromatography with column-switching and ultraviolet detection.

2000

A fully automated method including column-switching and isocratic high-performance liquid chromatography (HPLC) was developed for quantitative analysis of the new antidepressant reboxetine, a noradrenaline reuptake inhibitor. After serum injection into the HPLC system and on-line sample clean-up on a silica C8 (10x4.0 mm I.D.) clean-up column with an eluent consisting of 2.5% acetonitrile in deionized water, the chromatographic separation was performed on an analytical column (Lichrospher CN; 250x4.6 mm I.D.) with an eluent of acetonitrile-aqueous potassium phosphate buffer (0.008 M, pH 6.4) (50:50). The UV detector was set at 273 or 226 nm. The limit of quantification was about 15 ng/ml at…

Detection limitQuality ControlChromatographymedicine.diagnostic_testAdrenergic Uptake InhibitorsReboxetineMorpholinesAnalytical chemistryGeneral ChemistryHigh-performance liquid chromatographychemistry.chemical_compoundAutomationReboxetineColumn chromatographychemistryPotassium phosphateTherapeutic drug monitoringSpectrophotometrymedicineHumansSpectrophotometry UltravioletQuantitative analysis (chemistry)Chromatography High Pressure Liquidmedicine.drugJournal of chromatography. B, Biomedical sciences and applications
researchProduct

Effect of adolescent exposure to MDMA and cocaine on acquisition and reinstatement of morphine-induce CPP

2007

It is well known that an elevated percentage of ecstasy users also consume cocaine. Recently, it has been reported that a high frequency of heroin smokers first consumed heroin under the effects of ecstasy with the hope of reducing the stimulant effects of the latter drug. The aim of the present study was to evaluate the effect of exposure to MDMA and cocaine during adolescence on morphine-induced conditioned place preference (CPP) and reinstatement in adulthood. In the first experiment, adolescent mice were exposed to six injections of MDMA and three weeks later their response to the reinforcing properties of 40 mg/kg of morphine was evaluated using the CPP paradigm. All the treatment grou…

MaleNarcoticsN-Methyl-34-methylenedioxyamphetaminemedicine.medical_treatmentEcstasyPharmacologyExtinction PsychologicalHeroinMiceCocaineDopamine Uptake InhibitorsmedicineAnimalsDrug InteractionsBiological PsychiatryPharmacologyAnalysis of VarianceGateway drugAdrenergic Uptake InhibitorsBehavior AnimalDose-Response Relationship DrugMorphineMDMAExtinction (psychology)Conditioned place preferenceStimulantAnimals NewbornMorphineConditioning OperantPsychologyReinforcement Psychologypsychological phenomena and processesmedicine.drugProgress in Neuro-Psychopharmacology and Biological Psychiatry
researchProduct

Depressive-like symptoms in a reserpine-induced model of fibromyalgia in rats.

2015

Since the pathogenesis of fibromyalgia is unknown, treatment options are limited, ineffective and in fact based on symptom relief. A recently proposed rat model of fibromyalgia is based on central depletion of monamines caused by reserpine administration. This model showed widespread musculoskeletal pain and depressive-like symptoms, but the methodology used to measure such symptoms has been criticized. Evidence relates the high prevalence of pain and depression in fibromyalgia to common pathogenic pathways, most probably focused on the monoaminergic system. The present study aims at a validation of the reserpine model of fibromyalgia. For this purpose, rats undergoing this model have been …

MalePain ThresholdFood deprivationmedicine.medical_specialtyFibromyalgiaReserpineTime FactorsPhysiologyExperimental and Cognitive PsychologyMotor ActivityOpen fieldRats Sprague-DawleyBehavioral NeuroscienceAnimal modelFibromyalgiaMonoaminergicMedicineAnimalsDepression (differential diagnoses)Adrenergic Uptake Inhibitorsbusiness.industryDepressionFeeding BehaviorReserpinemedicine.diseaseTest adaptationRatsDisease Models AnimalInhibition PsychologicalHindlimb SuspensionPhysical therapyExploratory Behaviorbusinessmedicine.drugPhysiologybehavior
researchProduct

Role of NMDA and AMPA glutamatergic receptors in the effects of social defeat on the rewarding properties of MDMA in mice

2019

Exposure to social stress alters the response to drugs of abuse of experimental animals. Changes in the glutamatergic system seem to play a role in the effects of social defeat stress on the rewarding properties of cocaine and amphetamine. The aim of the present study was to evaluate the involvement of N-methyl-D-aspartate (NMDA) and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) glutamate receptors in the effects of social defeat on the conditioned place preference induced by 3,4-methylenedioxymethamphetamine (MDMA). Our hypothesis was that changes in these receptors could mediate the effects of social defeat on MDMA reward. Young adult male mice were exposed to an episode…

Maledrug addictionglutamate receptorN-Methyl-34-methylenedioxyamphetamineAMPA receptorPharmacologyReceptors N-Methyl-D-AspartateSocial defeatMice03 medical and health scienceschemistry.chemical_compoundstress0302 clinical medicineRewardConditioning PsychologicalmedicineAnimalsReceptors AMPASocial BehaviorAmphetamine030304 developmental biologySocial stress0303 health sciencesAdrenergic Uptake Inhibitorsbusiness.industryGeneral NeuroscienceMemantineMDMAconditioned place preferenceConditioned place preferencechemistrynervous systemCNQXbusinessExcitatory Amino Acid AntagonistsStress Psychological030217 neurology & neurosurgerymedicine.drug
researchProduct

Efficacy and safety of extended-release guanfacine hydrochloride in children and adolescents with attention-deficit/hyperactivity disorder: A randomi…

2014

AbstractGuanfacine extended-release (GXR), a selective α2A-adrenergic agonist, is a non-stimulant treatment for attention-deficit/hyperactivity disorder (ADHD). This study assessed the efficacy (symptoms and function) and safety of dose-optimized GXR compared with placebo in children and adolescents with ADHD. An atomoxetine (ATX) arm was included to provide reference data against placebo. Patients (6–17 years) were randomized at baseline to dose-optimized GXR (0.05–0.12mg/kg/day – 6–12 years: 1–4mg/day; 13–17 years: 1–7mg/day), ATX (10–100mg/day) or placebo for 4 or 7 weeks. The primary efficacy measure was change from baseline in ADHD Rating Scale version IV (ADHD-RS-IV). Key secondary me…

Malemedicine.medical_specialtyAdolescentClinical NeurologyAtomoxetine HydrochloridePlaceboDouble-Blind MethodRating scaleInternal medicineAdrenergic alpha-2 Receptor AgonistsmedicineHumansAttention deficit hyperactivity disorderPharmacology (medical)FunctionGuanfacine HydrochlorideChildAdverse effectBiological PsychiatryPsychiatric Status Rating ScalesPharmacologyAdrenergic Uptake InhibitorsDose-Response Relationship DrugPropylaminesAtomoxetinemedicine.diseaseGuanfacineGuanfacinePsychiatry and Mental healthAttention-deficit/hyperactivity disorderNeurologyTreatment efficacyAttention Deficit Disorder with HyperactivityDelayed-Action PreparationsAnesthesiaFemaleNeurology (clinical)Safetymedicine.symptomPsychologySomnolencemedicine.drugEuropean Neuropsychopharmacology
researchProduct

The novelty-seeking phenotype modulates the long-lasting effects of adolescent MDMA exposure.

2015

Exposure to drugs such as ethanol or cocaine during adolescence induces alterations in the central nervous system that are modulated by the novelty-seeking trait. Our aim was to evaluate the influence of this trait on the long-term effects of MDMA administration during adolescence on spontaneous behavior and conditioned rewarding effects in adulthood. Adolescent mice were classified as high or low novelty seekers (HNS or LNS) according to the hole-board test and received either MDMA (0, 10 or 20mg/kg PND 33-42) or saline. Three weeks later, having entered adulthood (PND>68), one set of mice performed the elevated plus maze and social interaction tests, while another set performed the condit…

Malemedicine.medical_specialtyElevated plus mazemedicine.drug_classN-Methyl-34-methylenedioxyamphetamineCentral nervous systemPoison controlExperimental and Cognitive PsychologyStriatumMotor ActivityAnxiolyticBehavioral NeuroscienceMiceInternal medicinemental disordersmedicineAnimalsSocial BehaviorAdrenergic Uptake InhibitorsBehavior AnimalNovelty seekingAssociation LearningMDMAEndocrinologymedicine.anatomical_structurePhenotypeAnesthesiaExploratory BehaviorConditioning OperantSerotoninPsychologypsychological phenomena and processesmedicine.drugPhysiologybehavior
researchProduct

Nortriptyline for smoking cessation: Release and human skin diffusion from patches

2009

Abstract The objective of this work was to develop a simple and inexpensive transdermal formulation containing Nortriptyline Hydrochloride (NTH) for smoking cessation support therapy. Hydroxypropyl-methyl-cellulose was chosen as polymer and a mixture of transdermal enhancers (selected from previous research) was incorporated. The formulations were characterised in terms of appearance, thickness, uniformity of NTH content, release and skin permeation. Release studies demonstrated controlled release for four formulations. Diffusion studies were performed through human heat separated epidermis (HHSE) using Franz Diffusion Cells (FDC). Patches provided different fluxes varying from 20.39 ± 7.09…

Time FactorsChemistry PharmaceuticalSkin AbsorptionPharmaceutical ScienceHuman skinNortriptylineIn Vitro TechniquesAdministration CutaneousPermeabilityDosage formExcipientsStratum corneummedicineHumansTransdermalMicroscopy ConfocalChromatographyAdrenergic Uptake Inhibitorsintegumentary systembusiness.industryPenetration (firestop)PermeationControlled releasemedicine.anatomical_structureNortriptyline HydrochlorideAnesthesiaMethacrylatesFemaleSmoking CessationbusinessInternational Journal of Pharmaceutics
researchProduct